Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Viruses 2013, 5(3), 981-997; doi:10.3390/v5030981
Article

Correlation of Naturally Occurring HIV-1 Resistance to DEB025 with Capsid Amino Acid Polymorphisms

1
, 2
, 1
, 3,* , 3
 and 4
Received: 1 March 2013; in revised form: 18 March 2013 / Accepted: 20 March 2013 / Published: 22 March 2013
(This article belongs to the Special Issue Cyclophilins and Viruses)
View Full-Text   |   Download PDF [407 KB, updated 25 March 2013; original version uploaded 22 March 2013]
Abstract: DEB025 (alisporivir) is a synthetic cyclosporine with inhibitory activity against human immunodeficiency virus type-1 (HIV-1) and hepatitis C virus (HCV). It binds to cyclophilin A (CypA) and blocks essential functions of CypA in the viral replication cycles of both viruses. DEB025 inhibits clinical HIV-1 isolates in vitro and decreases HIV-1 virus load in the majority of patients. HIV-1 isolates being naturally resistant to DEB025 have been detected in vitro and in nonresponder patients. By sequence analysis of their capsid protein (CA) region, two amino acid polymorphisms that correlated with DEB025 resistance were identified: H87Q and I91N, both located in the CypA-binding loop of the CA protein of HIV-1. The H87Q change was by far more abundant than I91N. Additional polymorphisms in the CypA-binding loop (positions 86, 91 and 96), as well as in the N-terminal loop of CA were detected in resistant isolates and are assumed to contribute to the degree of resistance. These amino acid changes may modulate the conformation of the CypA-binding loop of CA in such a way that binding and/or isomerase function of CypA are no longer necessary for virus replication. The resistant HIV-1 isolates thus are CypA-independent.
Keywords: DEB025; alisporivir; cyclophilin inhibitors; cyclosporines; HIV/retroviruses; HIV capsid; natural resistance DEB025; alisporivir; cyclophilin inhibitors; cyclosporines; HIV/retroviruses; HIV capsid; natural resistance
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Gallay, P.A.; Ptak, R.G.; Bobardt, M.D.; Dumont, J.-M.; Vuagniaux, G.; Rosenwirth, B. Correlation of Naturally Occurring HIV-1 Resistance to DEB025 with Capsid Amino Acid Polymorphisms. Viruses 2013, 5, 981-997.

AMA Style

Gallay PA, Ptak RG, Bobardt MD, Dumont J-M, Vuagniaux G, Rosenwirth B. Correlation of Naturally Occurring HIV-1 Resistance to DEB025 with Capsid Amino Acid Polymorphisms. Viruses. 2013; 5(3):981-997.

Chicago/Turabian Style

Gallay, Philippe A.; Ptak, Roger G.; Bobardt, Michael D.; Dumont, Jean-Maurice; Vuagniaux, Grégoire; Rosenwirth, Brigitte. 2013. "Correlation of Naturally Occurring HIV-1 Resistance to DEB025 with Capsid Amino Acid Polymorphisms." Viruses 5, no. 3: 981-997.



Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert